Follow-up cohort | MD | |||
---|---|---|---|---|
Male (n = 88) | Female (n = 219) | Male (n = 95) | Female (n = 169) | |
PF | 51.2 ± 8.6 | 53.1 ± 5.9 | −2.2* | 0.2 |
RP | 52.3 ± 6.1 | 53.0 ± 5.1 | −1.0 | 0.3 |
BP | 47.2 ± 8.2 | 48.2 ± 7.0 | −3.4** | −2.1* |
GH | 48.7 ± 9.5 | 49.4 ± 9.7 | −0.7 | −0.5 |
VT | 47.0 ± 8.0 | 47.8 ± 7.3 | 1.2 | 3.8** |
SF | 49.4 ± 10.4 | 49.2 ± 9.6 | −0.3 | 0.3 |
RE | 49.5 ± 6.7 | 50.3 ± 6.5 | 0.4 | 2.0 |
MH | 48.3 ± 9.6 | 49.0 ± 9.8 | 0.1 | 2.0 |
PCS | 49.8 ± 6.7 | 50.9 ± 5.3 | −5.2** | −4.0** |
MCS | 48.5 ± 7.2 | 49.1 ± 6.8 | 2.3* | 4.2** |